Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-02-28$1.35/sh−301$406→ 169,949 total
Footnotes (1)
- [F1]The total reported in Column 5 includes 5,786 shares acquired under Nabriva Therapeutics plc's 2018 Employee Stock Purchase Plan ("ESPP") on April 30, 2019 and 5,759 shares acquired under the ESPP on October 31, 2019.